Funakoshi A, Fujiyama T, Tatsuno K, Shimauchi T, et al. Secukinumab promotes engagement of cholecystokinin and its receptor in epidermal keratinocytes of psoriasis patients. J Dermatol 2020 Aug 13. doi: 10.1111/1346-8138.15552.
PMID: 32794215